Hynes Ne

631 total citations
10 papers, 540 citations indexed

About

Hynes Ne is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hynes Ne has authored 10 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hynes Ne's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and interferon and immune responses (2 papers). Hynes Ne is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and interferon and immune responses (2 papers). Hynes Ne collaborates with scholars based in Switzerland, Germany and Russia. Hynes Ne's co-authors include Bernd Groner, Marcel Mueller, Winfried S. Wels, Daniela Taverna, S. Nicholas Mason, Е. С. Корнилова, W Hoeck, K. Giesecke, Tilmann Wurtz and Ernst Reichmann and has published in prestigious journals such as Biochemistry, Endocrine Related Cancer and European Journal of Cancer Supplements.

In The Last Decade

Hynes Ne

10 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hynes Ne Switzerland 7 266 259 256 147 94 10 540
A. Lagarde Canada 10 255 1.0× 362 1.4× 138 0.5× 165 1.1× 90 1.0× 19 706
Flavia Novelli Italy 12 293 1.1× 316 1.2× 87 0.3× 94 0.6× 91 1.0× 22 579
Barbara J.M. Booth United States 14 202 0.8× 437 1.7× 610 2.4× 126 0.9× 43 0.5× 21 788
Charles Prussak United States 12 360 1.4× 564 2.2× 64 0.3× 378 2.6× 122 1.3× 35 1.0k
Caroline Ekblad Sweden 12 178 0.7× 329 1.3× 308 1.2× 87 0.6× 51 0.5× 13 563
Fritz Rudert Germany 14 96 0.4× 523 2.0× 120 0.5× 120 0.8× 59 0.6× 21 705
Marike Stassar Germany 12 144 0.5× 326 1.3× 167 0.7× 186 1.3× 23 0.2× 14 502
Ingrid Schuster Germany 6 159 0.6× 225 0.9× 152 0.6× 129 0.9× 50 0.5× 14 457
P O Livingston United States 11 130 0.5× 536 2.1× 339 1.3× 453 3.1× 26 0.3× 16 752
L. TOSTO United States 4 209 0.8× 544 2.1× 87 0.3× 106 0.7× 46 0.5× 5 702

Countries citing papers authored by Hynes Ne

Since Specialization
Citations

This map shows the geographic impact of Hynes Ne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hynes Ne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hynes Ne more than expected).

Fields of papers citing papers by Hynes Ne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hynes Ne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hynes Ne. The network helps show where Hynes Ne may publish in the future.

Co-authorship network of co-authors of Hynes Ne

This figure shows the co-authorship network connecting the top 25 collaborators of Hynes Ne. A scholar is included among the top collaborators of Hynes Ne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hynes Ne. Hynes Ne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Stephan, Christine, Sabine Zumstein-Mecker, Anne Boulay, et al.. (2004). 41 A potential for combining the rapamycin derivative RAD001 (everolimus) with the EGF/ErbB2/VEGF receptor tyrosine kinase inhibitor AEE788 in human cancer. European Journal of Cancer Supplements. 2(8). 16–16. 1 indexed citations
2.
Fiore, Lisa B., et al.. (1997). In mammary epithelial cells p53-mediated apoptosis in response to DNA damage is dependent on the agent and can be influenced by growth factors. Endocrine Related Cancer. 4(1). 55–66. 2 indexed citations
3.
Mason, S. Nicholas, et al.. (1996). Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.. PubMed. 13(2). 275–82. 72 indexed citations
4.
Ne, Hynes. (1993). Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.. PubMed. 4(1). 19–26. 112 indexed citations
5.
Корнилова, Е. С., Daniela Taverna, W Hoeck, & Hynes Ne. (1992). Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density.. PubMed. 7(3). 511–9. 57 indexed citations
6.
Wels, Winfried S., et al.. (1992). Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.. PubMed. 52(22). 6310–7. 163 indexed citations
7.
Reichmann, Ernst, et al.. (1988). The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent.. PubMed. 2(3). 259–65. 50 indexed citations
8.
Groner, Bernd, et al.. (1984). Expression of proviral DNA of mouse mammary tumour virus and its transcriptional control sequences.. PubMed. 1. 87–110. 6 indexed citations
9.
Ne, Hynes, U. Rahmsdorf, N. Kennedy, et al.. (1982). DNA mediated transfer and fate of a proviral gene of mouse mammary tumor virus in cultured cells.. PubMed. 85 Pt A. 159–71. 1 indexed citations
10.
Ne, Hynes, et al.. (1979). Control of cellular content of chicken egg white protein specific RNA during estrogen administration and withdrawal. Biochemistry. 18(4). 616–624. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026